American Century Companies Inc Bluebird Bio, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$1.32 - $4.83 $131,750 - $482,087	99,811 New	99,811 $137,000
Q3 2023 Nov 13, 2023	BUY	$3.02 - $4.05 $41,570 - $55,748	13,765 Added 45.11%	44,278 $134,000
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $43,858 - $79,071	15,720 Added 106.27%	30,513 $100,000
Q1 2023 May 11, 2023	SELL	$3.14 - $8.22 $17,904 - $46,870	-5,702 Reduced 27.82%	14,793 $47,000
Q4 2022 Feb 13, 2023	BUY	$5.77 - $8.49 $118,256 - $174,002	20,495 New	20,495 $141,000
Q4 2020 Feb 12, 2021	SELL	$27.5 - $37.92 $4.85 Million - $6.68 Million	-176,200 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$34.44 - $43.75 $5,579 - $7,087	162 Added 0.09%	176,200 $9.51 Million
Q2 2020 Aug 13, 2020	BUY	$27.12 - $45.97 $2,440 - $4,137	90 Added 0.05%	176,038 $10.7 Million
Q1 2020 May 14, 2020	SELL	$26.16 - $63.5 $8.48 Million - $20.6 Million	-324,207 Reduced 64.82%	175,948 $8.09 Million
Q4 2019 Feb 12, 2020	BUY	$46.96 - $61.67 $1.77 Million - $2.32 Million	37,642 Added 8.14%	500,155 $43.9 Million
Q3 2019 Nov 13, 2019	SELL	$59.47 - $93.1 $3.58 Million - $5.61 Million	-60,252 Reduced 11.53%	462,513 $42.5 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $3.03 Million - $4.21 Million	40,014 Added 8.29%	522,765 $66.5 Million
Q1 2019 May 14, 2019	BUY	$64.44 - $104.11 $1.83 Million - $2.96 Million	28,443 Added 6.26%	482,751 $0
Q4 2018 Feb 13, 2019	BUY	$59.1 - $93.26 $7.81 Million - $12.3 Million	132,228 Added 41.05%	454,308 $45.1 Million
Q3 2018 Nov 02, 2018	BUY	$88.86 - $117.49 $11.5 Million - $15.2 Million	129,749 Added 67.46%	322,080 $47 Million
Q2 2018 Aug 08, 2018	SELL	$99.64 - $127.59 $111,198 - $142,390	-1,116 Reduced 0.58%	192,331 $30.2 Million
Q1 2018 May 03, 2018	SELL	$105.8 - $150.94 $4.31 Million - $6.15 Million	-40,773 Reduced 17.41%	193,447 $33 Million
Q4 2017 Feb 02, 2018	BUY	$81.25 - $130.7 $591,906 - $952,149	7,285 Added 3.21%	234,220 $41.7 Million
Q3 2017 Nov 01, 2017	BUY	$57.74 - $91.42 $13.1 Million - $20.7 Million	226,935	226,935 $31.2 Million

Others Institutions Holding BLUE

# of Institutions

128

Shares Held

62.8M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$120 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$81.2 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$36.3 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$36.2 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$29.8 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $598M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account